GC WellBeing Corporation (KOSDAQ:234690)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Prescription Drugs	134.21B	108.44B	102.95B
Prescription Drugs Growth	23.76%	5.33%	-
Health Functional Food	32.80B	26.41B	17.58B
Health Functional Food Growth	24.19%	50.23%	-
Unallocated Adjutment	-2.33B	-1.05B	-
Total	164.68B	133.80B	120.53B
Total Growth	23.08%	11.01%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec 31, 2023
Overseas	590.13M
South Korea	119.94B
Total	120.53B

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 30, 2026

Data Sources Report a data error